Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures

Inclusion Criteria: 1\. Male adult patients scheduled for cystoscopy; additional procedures (e.g. ureteral stent placement, stent exchange, bladder biopsy, retrograde pyelogram) may be included. Exclusion Criteria: 1. History of analgesic abuse or opioid tolerance 2. Allergy to fentanyl or to any of the components of Lazanda® 3. Acute/chronic nasal problems such as rhinitis or sinusitis 4. Acute bronchial asthma / upper airway obstruction 5. Presence of bradycardia or history of seizures 6. Concomitant use of drugs that inhibit cytochrome P450 isoenzyme 3A4 (e.g., ritonavir, ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, nefazodone, amprenavir, aprepitant, diltiazem, erythromycin, fluconazole, fosamprenavir, monoamine oxidase inhibitors and verapamil) or exposure to these drugs 30 days prior to placement on the study. 7. Concomitant use of vasoconstrictive nasal decongestants (e.g., oxymetazoline, phenylephrine, xylometazoline) 8. Numeric Rating Scale (NRS) pain score more than 0 at baseline 9. Any situation or condition which, in the investigator's opinion, puts the subject at significant risk, or could confound the study results.